Isolation of Trypanosoma brucei gambiense from Cured and Relapsed Sleeping Sickness Patients and Adaptation to Laboratory Mice

How to Shorten Patient Follow‐Up after Treatment forTrypanosoma brucei gambienseSleeping Sickness

(2010) Dieudonné Mumba Ngoyi et al.   JOURNAL OF INFECTIOUS DISEASES

Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial

(2009) Gerardo Priotto et al.   LANCET

Human African trypanosomiasis

(2009) Reto Brun et al.   LANCET

Murine Models for Trypanosoma brucei gambiense Disease Progression—From Silent to Chronic Infections and Early Brain Tropism

(2009) Christiane Giroud et al.   PLoS Neglected Tropical Diseases

Trypanosoma brucei gambiense Type 1 populations from human patients are clonal and display geographical genetic differentiation

(2008) Liam J. Morrison et al.   INFECTION GENETICS AND EVOLUTION

Ever-increasing complexities of diamidine and arsenical crossresistance in African trypanosomes

(2008) Harry P. de Koning   TRENDS IN PARASITOLOGY

Eliminating Human African Trypanosomiasis: Where Do We Stand and What Comes Next?

(2008) Pere P Simarro et al.   PLOS MEDICINE